Cure Today18m
FDA Approves Revuforj for Relapsed/Refractory Acute Leukemia Subset
Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.
Cure Today19m
How Circulating Tumor Cell Count Can Inform Prostate Cancer Treatment
Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...
Cure Today4h
FDA Approves Danziten for Leukemia Subset That Does Not Require Fasting
Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...
Cure Today6h
Quincy Jones Died of Cancer, Dwayne Johnson Connects with a Fan with Cancer and More
From producer Quincy Jones’ death from pancreatic cancer to an inspiring moment between The Rock and a fan at a store, here’s ...
Cure Today8h
Treatment Options Are Not ‘One-Size-Fits-All’ in Head and Neck Cancers
In patients with oropharyngeal cancer, deciding whether radiation therapy or surgery is the best option depends on their lifestyle and their values.
Cure Today22h
Anti-TIGIT Therapy-Based Treatment Combo Did Not Improve Survival in Extensive-Stage SCLC
Vibostolimab/Keytruda regimen did not improve overall survival compared to Tecentriq in extensive-stage SCLC patients. Median ...